Antibodies against fibrinogen in pregnant women, in post delivery women and in the newborns

Thrombosis and Haemostasis

Volumn 79, Issue 5, 1998, Pages 963-968

  Kondera Anasz, Zdzislawa ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FIBRINOGEN ANTIBODY; FIBRINOGEN DEGRADATION PRODUCT; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CORD SERUM; DELIVERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; NEWBORN; NORMAL HUMAN; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL;

EID: 0031966721     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615103     Document Type: Article

References (39)

1. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 1994; 101: 488-92.
2. Estelles A, Gilabert J, Espana F, Aznar J, Galbis M. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol 1991; 165: 138-42.
3. Ho CH, Yang ZL. The predictive value of the hemostasis parameters in the development of preeclampsia. Thromb Haemost 1992; 67: 214-8.
4. 2-terminal part of human fibrinogen. Thromb Res 1976; 8: 639-58.
5. Plow EF, Edgington TS. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. J Clin Invest 1973; 52: 273-82.
6. Wilner GD, Hsieh KH, Thomas DW. Immunology of fibrinogen: Comparisons of serologic and cellular immune responses to human fibrinopeptide B (hFPB). Ann NY Acad Sci 1981; 370: 528-35.
7. Brönnimann R. Kongenitale Afibrinogenämie. Mitteilung eines Falles mit multiplen Knochenzysten und Bildung eines spezifischen Antikörpers (Antifibrinogen) nach Bluttransfusionen. Acta Haematol 1954; 11: 40-51.
8. Plow EF, Edgington TS. Immune responses to the cleavage associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments. J Clin Invest 1975; 56: 1509-18.
9. Whitaker AN, McFarlane JR, Rowe EA, Lee K, Masci PP. Measurement of autoantibodies against fibrinogen and fibrin degradation products by enzyme-linked immunoassay. Thromb Haemost 1985; 53: 80-5.
10. Michalski A, Kondera-Anasz Z, Gonciarz Z. Autoantibodies against fibrinogen during Interferon therapy in patients with chronic viral hepatitis. Int J Gastroenterol Hepatol 1995; 2 (Suppl): 226-7.
11. Mac Lean MA, Wilson R, Thompson JA, Krishnamurthy S, Walker JJ. Changes in immunologic parameters in normal pregnancy and spontaneous abortion. Am J Obstet Gynecol 1991; 165: 890-5.
12. Cierniewski CS, Plow E, Edgington TS. Conformation of the carboxy-terminal region of the A alfa-chain of fibrinogen as elucidated by immunochemical analyses. Eur J Biochem 1984; 141: 489-96.
13. Cierniewski CS, Janiak A, Nowak P, Augustyniak W. Reactivity of fibrinogen derivatives with antisera to human fibrin D-dimer and its γ-γ chain remnant. Thromb Haemost 1982; 48: 33-7.
14. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haemat 1957; 17: 237-46.
15. Itzhaki RF, Gill DMA. A microbiuret method for estimating proteins. Anal Biochem 1969; 9: 401-11.
16. Merskey C, Lalezari P, Johnson A. A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc Soc Exp Biol 1969; 131: 871-80.
17. McDonagh J, Messel H, McDonagh RF, Murano G, Blombäck B. Molecular weight analysis of fibrinogen and fibrin chains by an improved sodium dodecyl sulfate gel electrophoresis method. Biochim Biophys Acta 1972; 257: 135-42.
18. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
19. MacLean MA, Wilson R, Thomson JA, Krishnamurthy S, Walker JJ. Immunological changes in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1992; 43: 167-72.
20. Proietti AB, Johnson MJ, Proietti FA, Repke JT, Bell WR. Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-bead agglutination. Obstet Gynecol 1991; 77: 696-700.
21. Van Wersch JWJ, Ubachs JMH. Blood coagulation and fibrinolysis during normal pregnancy. Eur J Clin Chem Clin Biochem 1991; 29: 45-50.
22. Lindoff C, Lecander J, Åstedt B. Fibrinolytic components in individual consecutive plasma samples during normal pregnancy. Fibrinolysis 1993; 7: 190-4.
23. Bremer HA, Brommer EJP, Wallenburg HCS. Effects of labor and delivery on fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1994; 55: 163-8.
24. Bremme K, Östlund E, Almqvist I, Heinonen K, Blombäck M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992; 80: 132-7.
25. Plow EF, Edgington TS. Surface makers of fibrinogen and its physiologic derivatives revealed by antibody probes. Semin Thromb Haemost 1982; 8: 36-56.
26. Levesque JP, Hatzfeld A, Hatzfeld D. Mitogenic properties of major extra-cellular proteins. Immunol Today 1991; 12: 258-62.
27. Stoll B, Lee FK, Hale E, Schwartz D, Holmes R, Ashby R, Czerkinsky C, Nahmias AJ. Immunoglobulin secretion by the normal and the infected newborn infant. J Pediatr 1993; 122: 780-6.
28. Bell SA, Du Clos TW, Khursigara G, Picazo JJ, Rubin RL. Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the toxic oil syndrome. J Autoimmun 1995; 8: 293-303.
29. De Vries A, Rosenberg T, Kochwa S, Boss J. Precipitating antifibrinogen antibody appearing after fibrinogen infusions in a patient with congenital afibrinogenemia. Am J Med 1961; 30: 486-94.
30. Ra'anani P, Levi Y, Varon D, Gitel S, Martinowitz U. Congenital afibrinogenemia with bleeding, bone cysts and antibodies to fibrinogen. Harefuah 1991; 121: 291-3.
31. Mammen EF, Schmidt KP, Barnhart MI. Thrombophlebitis migrans associated with circulating antibodies against fibrinogen. A case report. Thrombos Diathes Haemorrh 1967; 18: 605-11.
32. Marciniak E, Greenwood MF. Acquired coagulation inhibitor delaying fibrinopeptide release. Blood 1979; 1: 81-92.
33. Mertas A, Kondera-Anasz Z. Antifibrinogen antibodies in serum of blood recipients with post-transfusion reactions. Clin Biochem Revs 1993; 14: 199.
34. Ghosh S, McEvoy P, McVerry BA. Idiopathic autoantibody that inhibits fibrin monomer polymerization. Br J Haematol 1983; 53: 65-72.
35. Hoots WK, Carrell NA, Wagner RH, Cooper HA, McDonagh J. A naturally occurring antibody that inhibits fibrin polymerization. N Engl J Med 1981; 304: 857-61.
36. Rosenberg RD, Colman RW, Loand L. A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemia. Br J Haematol 1974; 26: 269-84.
37. Ruiz-Arquelles A. Spontaneous reversal of acquired autoimmune dysfibrinogenemia probably due to an antiidiotypic antibody directed to an interspecies cross-reactive idiotype expressed on antifibrinogen antibodies. J Clin Invest 1988; 82: 958-63.
38. Boreham PFL, Facer CA. Autoimmunity in trypanosome infections. II. Anti-fibrin/fibrinogen(Anti-F) autoantibody in Trypanosoma (Trypanozoon) brucei infections of the rabbit. Int J Parasitol 1974; 4: 601-7.
39. Thoongsuwan S, Cox HW, Rickman WJ. Antibody to fibrinogen/fibrin products (anti-F) in malaria, babesiosis and trypanosomiasis of rodents. J Parasitol 1979; 65: 426-9.